Characterisation of gastrointestinal and thoracic neuroendocrine tumours

被引：0

作者：

Baudin, E. ^{[1
]}

Scoazec, J. -Y. ^{[1
]}

Caramella, C. ^{[1
]}

Leboulleux, S. ^{[1
]}

Caron, O. ^{[1
]}

Deandreis, D. ^{[1
]}

Duvillard, P. ^{[1
]}

Lumbroso, J. ^{[1
]}

de Baere, T. ^{[1
]}

Deschamps, F. ^{[1
]}

Goere, D. ^{[1
]}

Dumont, F. ^{[1
]}

Elias, D. ^{[1
]}

Malka, D. ^{[1
]}

Boige, V. ^{[1
]}

Schlumberger, M. ^{[1
]}

Guigay, J. ^{[1
]}

Planchard, D. ^{[1
]}

Ducreux, M. ^{[1
]}

机构：

[1] Gustave Roussy, Ctr Expert RENATEN Tumeurs Neuroendocrines, F-94805 Villejuif, France

来源：

ONCOLOGIE | 2013年 / 15卷 / 10-11期

关键词：

Neuroendocrine tumours; Prognosis factors; Diagnostic impact; Characterisation; Response to treatment; Multidisciplinary expertise; RENATEN and TENPATH networks; ENETS CONSENSUS GUIDELINES; PROGNOSTIC-FACTORS; ENDOCRINE TUMORS; MANAGEMENT; NEOPLASMS;

D O I：

10.1007/s10269-013-2343-1

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Once the diagnosis of a neuroendocrine tumour has been made, characterisation is an essential step before therapy. It comes before the decision regarding treatment is made. This requires a multidisciplinary team of experts located in specialist centres that currently make up the RENATEN and TENPATH networks. It is directed by knowledge of the location of the primary tumour and anatomical pathological differentiation. The aim of this characterisation step is to highlight factors that may have an impact on the diagnosis and the prognosis or predict the response to treatment.

引用

页码：505 / 509

页数：5

共 50 条

[1] Neuroendocrine gastrointestinal tumours
Oberg, K
ANNALS OF ONCOLOGY, 1996, 7 (05) : 453 - 463
[2] Neuroendocrine tumours of the gastrointestinal tract
Plöckinger, U
Wiedenmann, B
ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2004, 42 (06): : 517 - 526
[3] Gastrointestinal neuroendocrine tumours: Diagnostic challenges
Pehlivanoglu, B.
Doganavsargil, B.
Oruc, N.
Sezak, M.
VIRCHOWS ARCHIV, 2015, 467 : S131 - S132
[4] Histopathologic variations in gastrointestinal neuroendocrine tumours
Zamfir, L. A. -Maria
Pavel, A.
Farcas, M.
Nichita, L.
Micu, G.
Gramada, E.
Popp, C.
VIRCHOWS ARCHIV, 2017, 471 : S179 - S179
[5] Interventional treatment of gastrointestinal neuroendocrine tumours
Ahlman, H
Wängberg, B
Jansson, S
Friman,S
Olausson, M
Tylén, U
Nilsson, O
DIGESTION, 2000, 62 : 59 - 68
[6] Molecular pathology and genetics of gastrointestinal neuroendocrine tumours
Lewis, Mark A.
Yao, James C.
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2014, 21 (01) : 22 - 27
[7] Current diagnosis and management of gastrointestinal neuroendocrine tumours
Jensen, RT
DIGESTIVE AND LIVER DISEASE, 2001, 33 (03) : 212 - 214
[8] Gastrointestinal manifestations of neuroendocrine tumours: their investigation and management
Sagar, Vandana M.
Cooper, Sheldon C.
Johnson, Jill
Shetty, Shishir
Shah, Tahir
POSTGRADUATE MEDICAL JOURNAL, 2017, 93 (1102) : 494 - 497
[9] Surgical strategy in the treatment of gastrointestinal neuroendocrine tumours
Falconi, M
Bettini, R
Scarpa, A
Capelli, P
Pederzoli, P
ANNALS OF ONCOLOGY, 2001, 12 : S101 - S103
[10] Differential expression of microRNAs in gastrointestinal neuroendocrine tumours
Lopez Panqueva, R. D. Pilar
Vega Neira, S.
VIRCHOWS ARCHIV, 2018, 473 : S292 - S292

← 1 2 3 4 5 →